Trump tariffs reside: President says US will ‘soon’ slap levies on chips and prescription drugs
US shares tumbled on Thursday whereas the greenback sank, as buyers wager…
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Buyers of Regeneron Prescription drugs By Investing.com
Faruqi & Faruqi, LLP Securities Litigation Accomplice James (Josh) Wilson Encourages Buyers…
Bennett C. Frank of Ionis Prescription drugs sells $222,113 in inventory By Investing.com
Bennett C. Frank, Govt Vice President and Chief Scientific Officer at Ionis…
Ironwood Prescribed drugs shares surge on competitor’s woes By Investing.com
Investing.com -- Shares of Ironwood Prescribed drugs (NASDAQ:) soared by as a…
EyePoint Prescribed drugs Experiences Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
WATERTOWN, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Prescribed drugs, Inc.…
Ars Prescribed drugs’ chief enterprise officer sells $1.77m in inventory By Investing.com
SAN DIEGO—Justin Chakma, the Chief Business Officer of ARS Prescribed drugs, Inc.…
60 Levels Prescribed drugs launches babesiosis drug trial By Investing.com
WASHINGTON - 60 Levels Prescribed drugs Inc. (NASDAQ: SXTP; SXTPW), an organization…
Ars Prescribed drugs director Laura Shawver sells shares for $2.69 million By Investing.com
Laura Shawver, a director at ARS Prescribed drugs, Inc. (NASDAQ:SPRY), has reported…
Lexicon Prescribed drugs inventory hits 52-week low at $0.73 By Investing.com
In a difficult yr for Lexicon Prescribed drugs (NASDAQ:) Inc., the corporate's…
Catalyst Prescribed drugs chief compliance officer sells $286,703 in inventory By Investing.com
CORAL GABLES, FL—Brian Elsbernd, the Chief Compliance and Authorized Officer of Catalyst…
